2Alpha, 3alpha-epithio-5alpha-androstan-17beta-YL 1-methoxycyclopentyl ether (10364-S), a new orally active anti-estrogenic steroid.
D000232:Adenofibroma / Q000188:drug therapy; D000731:Androstanes / Q000008:administration & dosage / Q000494:pharmacology*; D000732:Androstanols; D000818:Animals; D002369:Castration; D004958:Estradiol / Q000008:administration & dosage / Q000378:metabolism; D004965:Estrogen Antagonists; D004987:Ethers / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D005474:Fluoxymesterone / Q000008:administration & dosage / Q000494:pharmacology; D008321:Mammary Glands, Animal / Q000187:drug effects*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D009929:Organ Size; D010053:Ovary / Q000502:physiology; D051381:Rats; D013440:Sulfides / Q000008:administration & dosage / Q000494:pharmacology; D013778:Tetrazolium Salts / Q000378:metabolism; D014599:Uterus / Q000187:drug effects*; D014621:Vagina / Q000187:drug effects* / Q000502:physiology
D000731:Androstanes; D000732:Androstanols; D004965:Estrogen Antagonists; D004987:Ethers; D013440:Sulfides; D013778:Tetrazolium Salts; D004958:Estradiol; D005474:Fluoxymesterone; C006242:mepitiostane